trial
Treatment of Cognitive Impairment in Schizophrenia
Impairments in everyday functional outcomes are very common in people with schizophrenia and these impairments are associated with deficits in cognitive functioning. Cognitive enhancement has been proposed as a pathway to disability reduction. This pathway has been clearly defined in terms of the required clinical trials methods, with primary (cognitive) and secondary (functional) outcome measures well validated. Second generation (Newer, Atypical) antipsychotic medications have been thoroughly evaluated with their cognitive enhancement potential. Read more about this session.
2010-2011 Psychiatric Pharmacy Review Course - ACPE Credit Only
The Psychiatric Pharmacy Review Course (Review Course) is an excellent course of study and resource for those seeking a review of psychopharmacology and current standards of care. Read more about this session.
Application of External Review for Subject Selection in a Schizophrenia Trial
No abstract available
An Exploratory, Open Trial of Fluoxetine Treatment of Juvenile Fibromyalgia
No abstract available
Trial of Prevention and Reduction of Obesity Through Active Living in Clinical Settings: A Randomized Controlled Trial [Original Investigation]
Background The efficacy of physical activity with a healthful diet to reduce obesity is established; however, little is known about the translation of effective lifestyle strategies for obesity reduction in primary care settings.
The effect of adding psychodynamic therapy to antidepressants in patients with major depressive disorder. A systematic review of randomized clinical trials with meta-analyses and trial sequential analyses
Publication year: 2012Source:Journal of Affective Disorders, Volume 137, Issues 1–3Janus Christian Jakobsen, Jane Lindschou Hansen, Erik Simonsen, Christian Gluud
A double blind randomized trial of unilateral left and bilateral prefrontal cortex transcranial magnetic stimulation in treatment resistant major depression
Publication year: 2012Source:Journal of Affective DisordersPaul B. Fitzgerald, Kate E. Hoy, Sally E. Herring, Susan McQueen, Amy V.J. Peachey, Rebecca A. Segrave, Jerome Maller, Phillip Hall, Z. Jeff Daskalakis
Continued cannabis use and outcome in first-episode psychosis: data from a randomized, open-label, controlled trial.
Faber G, Smid HG, Van Gool AR, et al. | | |